Evidence· July 4, 2026 · 16 min read
Topic
Specialty Pharmacy
Limited distribution, hub services, fulfillment routing, REMS friction, and payer-channel coordination.
Approvals· July 3, 2026 · 17 min read
Icotyde (icotrokinra) FDA approval and oral IL-23 psoriasis access
By Ran Chen#FDA Approval#Dermatology#Immunology
Approvals· July 3, 2026 · 17 min read
Lynavoy (linerixibat) FDA approval: first IBAT inhibitor for PBC pruritus
By Ran Chen#FDA Approval#GI and Liver#Rare Disease
Approvals· July 3, 2026 · 17 min read
Yuviwel (navepegritide) FDA approval and once-weekly achondroplasia access
Approvals· July 2, 2026 · 18 min read
Lifyorli (Relacorilant) FDA Approval and Ovarian Cancer Access
By Ran Chen#FDA Approval#Pivotal Trials#Payer Criteria
Generics· June 24, 2026 · 18 min read
When is Generic Imbruvica Available? The 522-Patent Wall and Litigation Settlement Reality
By Ran Chen#Orange Book#Generics#Generic Entry
Manufacturing· June 14, 2026 · 10 min read
Anesthesia injectable shortage: 342 records, 99 not fully available, 8-year median
Policy· June 10, 2026 · 9 min read
What's in short supply: 1,146 shortages, two-thirds injectable, and an anesthesia crisis
By Ran Chen#Supply Chain#FDA Approval#Drug Pricing
Pricing & Access· June 6, 2026 · 10 min read
GLP-1 pharmacy vs medical benefit: routing, cost-sharing, and PA impact
By Ran Chen#GLP-1#Pharmacy Benefit#Medical Benefit
Specialty· June 6, 2026 · 14 min read